Clinical Trial Update: The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract [Phase 3]

View source ↗

Summary

Phase 3 ASPIRE trial completed evaluating strategies to reduce malaria and reproductive tract infections during pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis
• Pregnancy Malaria
• Trichomonas Vaginitis

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Pregnancy Malaria, Bacterial Vaginoses | Phase 3 | Status: COMPLETED